Abstrakt: |
Antibacterials, Antibiotics, Antiinfectives, Antimicrobial Resistance, Antimicrobials, Colistin, Colistin Therapy, Critical Care Medicine, Drug Resistance, Drugs and Therapies, Epidemiology, Glycopeptide Antibiotics, Glycopeptides Therapy, Health and Medicine, Hospitals, Intensive Care Medicine, Membrane Proteins, Peptides, Pharmaceuticals, Polymyxins, Pore Forming Cytotoxic Proteins, Vancomycin Therapy Keywords: Antibacterials; Antibiotics; Antiinfectives; Antimicrobial Resistance; Antimicrobials; Colistin; Colistin Therapy; Critical Care Medicine; Drug Resistance; Drugs and Therapies; Epidemiology; Glycopeptide Antibiotics; Glycopeptides Therapy; Health and Medicine; Hospitals; Intensive Care Medicine; Membrane Proteins; Peptides; Pharmaceuticals; Polymyxins; Pore Forming Cytotoxic Proteins; Vancomycin Therapy EN Antibacterials Antibiotics Antiinfectives Antimicrobial Resistance Antimicrobials Colistin Colistin Therapy Critical Care Medicine Drug Resistance Drugs and Therapies Epidemiology Glycopeptide Antibiotics Glycopeptides Therapy Health and Medicine Hospitals Intensive Care Medicine Membrane Proteins Peptides Pharmaceuticals Polymyxins Pore Forming Cytotoxic Proteins Vancomycin Therapy 754 754 1 04/03/23 20230407 NES 230407 2023 APR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Research findings on glycopeptide antibiotics are discussed in a new report. [Extracted from the article] |